Elzomor Hossam, Taha Hala, Nour Radwa, Aleieldin Adel, Zaghloul M Saad, Qaddoumi Ibrahim, Alfaar Ahmad S
a Pediatric Oncology Department , Children's Cancer Hospital Egypt , Cairo , Egypt.
b Egyptian National Cancer Institute, Cairo University , Cairo , Egypt.
Ophthalmic Genet. 2017 Jul-Aug;38(4):345-351. doi: 10.1080/13816810.2016.1227995. Epub 2017 Jan 13.
Retinoblastoma poses a substantial burden in developing countries. We conducted this study to assess the effect of implementing a multidisciplinary approach and standardized protocols for treating pediatric patients with retinoblastoma at the Children's Cancer Hospital Egypt (CCHE).
In January 2011, the CCHE implemented standardized protocols for the diagnosis, treatment, and reporting of retinoblastoma cases. The hospital also introduced a new retinoblastoma management algorithm and data analysis system. In this study, we compared the pathologic features, tumor invasiveness, reporting, and survival of 276 pediatric patients who underwent enucleations of 290 eyes before or after the implementation of the retinoblastoma protocols.
Time to enucleation (indicating time needed for decision taking) decreased significantly within the neoadjuvant chemotherapy group for intraocular disease after January 2011 (68.7 ± 48 weeks vs. 47.3 ± 28.3 weeks; p < 0.05). Mean optic nerve stump length increased from 5.6 mm in the earlier period to 7.2 mm in the later period (p = 0.004). The overall quality of pathology reporting also improved during the later period. The probability of 3-year survival was significantly higher for patients during the later period (94.2% vs. 79.2%; p = 0.018).
The implementation of standardized protocols and a multidisciplinary approach improved reporting; discrepancies in disease classification and the amount of missing data were reduced; and quality measures and prognostic capabilities of the team were substantially improved. Such established data-driven practice supports faster decision making to enucleate diseased eyes and save patients' lives through providing measurable indicators.
视网膜母细胞瘤在发展中国家造成了沉重负担。我们开展这项研究,以评估在埃及儿童癌症医院(CCHE)实施多学科方法和标准化方案治疗小儿视网膜母细胞瘤患者的效果。
2011年1月,CCHE实施了视网膜母细胞瘤病例诊断、治疗及报告的标准化方案。该医院还引入了一种新的视网膜母细胞瘤管理算法和数据分析系统。在本研究中,我们比较了276例接受290只眼眼球摘除术的小儿患者在视网膜母细胞瘤方案实施前后的病理特征、肿瘤侵袭性、报告情况及生存率。
2011年1月后,新辅助化疗组眼内疾病患者的眼球摘除时间(即决策所需时间)显著缩短(68.7±48周对47.3±28.3周;p<0.05)。视神经残端平均长度从早期的5.6毫米增加到后期的7.2毫米(p=0.004)。后期病理报告的整体质量也有所提高。后期患者3年生存率显著更高(94.2%对79.2%;p=0.018)。
标准化方案和多学科方法的实施改善了报告情况;疾病分类差异和缺失数据量减少;团队的质量指标和预后能力大幅提高。这种既定的数据驱动做法通过提供可衡量指标,支持更快地做出摘除患眼的决策并挽救患者生命。